financetom
Business
financetom
/
Business
/
Chemours Expects to Meet High-End of Fiscal Q2 Net Sales Outlook
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Chemours Expects to Meet High-End of Fiscal Q2 Net Sales Outlook
Jun 18, 2025 5:04 AM

07:30 AM EDT, 06/18/2025 (MT Newswires) -- Chemours ( CC ) said Wednesday that it now expects fiscal Q2 net sales to reach the high end of its previously announced forecast of a low to mid-teens sequential increase.

Analysts polled by FactSet expect a fiscal Q2 net sales of $1.56 billion.

The company also said it now expects fiscal Q2 adjusted EBITDA of $215 million to $225 million as adjusted EBITDA from its Titanium Technologies segment is estimated to decline by about 15% sequentially due to operational disruptions at certain US sites.

Chemours ( CC ) previously estimated a 40% to 45% increase in fiscal Q2 adjusted EBITDA.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Amazon to invest $11 billion in Indiana to build data centers
Amazon to invest $11 billion in Indiana to build data centers
Apr 25, 2024
(Reuters) - Amazon.com's ( AMZN ) cloud-computing arm said it would invest $11 billion in Indiana to build data centers, marking the state's largest capital investment, and promising at least 1,000 jobs. The announcement by Amazon Web Services on Thursday builds on the online retail giant's already strong presence in the state, where it employs 26,000 full- and part-time staff....
AbbVie's Rinvoq shows superiority to Regeneron's Dupixent in study
AbbVie's Rinvoq shows superiority to Regeneron's Dupixent in study
Apr 25, 2024
April 25 (Reuters) - AbbVie ( ABBV ) said on Thursday its drug, Rinvoq, for treating a type of inflammatory skin condition showed superior efficacy to Regeneron Pharmaceuticals ( REGN ) and Sanofi's Dupixent in a late-stage head-to-head study. ...
Star Diamond and Minespider Launch G7-Compliant
Star Diamond and Minespider Launch G7-Compliant "Diamond Passport"
Apr 25, 2024
08:15 AM EDT, 04/25/2024 (MT Newswires) -- Star Diamond ( SHGDF ) and Minespider, a traceability platform for tracking minerals and raw materials, said on Thursday that they launched the Diamond Passport to comply with new G7 rules. The passport contains all key information about the diamond, including its provenance data, the diamond's unique DNA, such as size, shape, color,...
Altria tops first quarter sales on higher pricing, robust demand for smokeless alternatives
Altria tops first quarter sales on higher pricing, robust demand for smokeless alternatives
Apr 25, 2024
April 25 (Reuters) - Altria Group ( MO ) topped quarterly sales expectations on Thursday, driven by higher pricing and rising demand for alternatives to conventional tobacco products. Like other tobacco giants, Altria ( MO ) has been revamping its portfolio of products to keep up with consumers switching from traditional tobacco products to vapes or other alternatives and as...
Copyright 2023-2026 - www.financetom.com All Rights Reserved